Mitochondrial control of neuron death and its role in neurodegenerative disorders

被引:1
|
作者
Jordán, J
Ceña, V
Prehn, JHM
机构
[1] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete, Spain
[2] Univ Castilla La Mancha, Fac Med, Dpto Ciencias Med, Albacete, Spain
[3] Royal Coll Surgeons Ireland, Dept Physiol, Dublin 2, Ireland
关键词
apoptosis; necrosis; apoptosome; caspase; permeability transition pore; mitochondria;
D O I
10.1007/BF03179878
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetic or functional mitochondrial alterations can result in the initiation of cell death programs that are believed to contribute to cell death in diabetes, ageing and neurodegenerative disorders. Mitochondria are being considered the main link between cellular stress signals activated during acute and chronic nerve cell injury, and the execution of nerve cell death. This second function of mitochondria is regulated by several families of proteins that can trigger an increase in permeability of the outer and/or inner mitochondrial membrane. One example of this is the formation of the mitochondrial permeability transition pore (MPTP). This process can trigger the release of cell death-inducing factors from mitochondria, as well as a dissipation of the mitochondrial transmembrane potential, depletion of ATP, and increased free radical formation. Among the factors released from mitochondria are cytochrome c, the apoptosis inductor factor (AIF), and caspases. We review the role of the MPTP in diverse physiological and pathological processes, including neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). The design of drugs that could interfere with the functions of the MPTP could allow novel therapeutic approaches for the treatment of acute and chronic nerve cell injury.
引用
收藏
页码:129 / 141
页数:13
相关论文
共 50 条
  • [21] Mitochondrial Fatty Acids and Neurodegenerative Disorders
    Kastaniotis, Alexander J.
    Autio, Kaija J.
    Nair, R. Remya
    NEUROSCIENTIST, 2021, 27 (02): : 143 - 158
  • [22] Disturbed mitochondrial dynamics and neurodegenerative disorders
    Burte, Florence
    Carelli, Valerio
    Chinnery, Patrick F.
    Yu-Wai-Man, Patrick
    NATURE REVIEWS NEUROLOGY, 2015, 11 (01) : 11 - 24
  • [23] Mitochondrial permeability as a target for neurodegenerative disorders
    Williams, Larry
    Wu, Frank Y.
    Hamilton, Greg
    DRUGS OF THE FUTURE, 2006, 31 (12) : 1083 - 1098
  • [24] Mitochondrial dysfunction in neurodegenerative disorders and ageing
    Turner, C
    Schapira, AHV
    NEUROPATHOLOGY AND GENETICS OF DEMENTIA, 2001, 487 : 229 - 251
  • [25] Copper interactions with DNA of chromatin and its role in neurodegenerative disorders
    M.Govindaraju
    H.S.Shekar
    S.B.Sateesha
    P.Vasudeva Raju
    K.R.Sambasiva Rao
    K.S.J.Rao
    A.J.Rajamma
    JournalofPharmaceuticalAnalysis, 2013, 3 (05) : 354 - 359
  • [26] Tau function and dysfunction in neurons - Its role in neurodegenerative disorders
    Avila, J
    Lim, F
    Moreno, F
    Belmonte, C
    Cuello, AC
    MOLECULAR NEUROBIOLOGY, 2002, 25 (03) : 213 - 231
  • [27] Mechanisms of cell death in neurodegenerative disorders
    Jellinger, KA
    Stadelmann, C
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2000, (59): : 95 - 114
  • [28] The enigma of cell death in neurodegenerative disorders
    Jellinger, KA
    Stadelmann, C
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 8, 2000, 8 : 21 - 36
  • [29] Mechanisms of cell death in neurodegenerative disorders
    Jellinger, KA
    Stadelmann, C
    ADVANCES IN DEMENTIA RESEARCH, 2000, : 95 - 114
  • [30] Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism-related Molecule in Neurodegeneration
    Khodagholi, Fariba
    Shaerzadeh, Fatemeh
    Montazeri, Fateme
    CURRENT DRUG TARGETS, 2018, 19 (08) : 973 - 985